2D graphene oxide–aptamer conjugate materials for cancer diagnosis
Source abstract
Abstract
Abstract 2D graphene oxide (GO) with large surface area, multivalent structure can easily bind single-stranded DNA/RNA (aptamers) through hydrophobic/π-stacking interactions, whereas aptamers having small size, excellent chemical stability and low immunogenicity bind to their targets with high affinity and specificity. GO–aptamer conjugate materials synthesized by integrating aptamers with GO can thus provide a better alternative to antibody-based strategies for cancer diagnostic and therapy. Moreover, GO’s excellent fluorescence quenching properties can be utilized to develop efficient fluorescence-sensing platforms. In this review, recent advances in GO–aptamer conjugate materials for the detection of major cancer biomarkers have been discussed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications · Graphene research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Etzioni, R. et al. The case for early detection. Nat. Rev. Cancer 3, 243–252 (2003).10.1038/nrc1041 ↗
2. Zhou, Y. et al. Diagnosis of cancer as an emergency: a critical review of current evidence. Nat. Rev. Clin. Oncol. 14, 45–56 (2017).10.1038/nrclinonc.2016.155 ↗
3. Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926–930 (2018).10.1126/science.aar3247 ↗
4. Kalinich, M. D. & Haber, A. Cancer detection: seeking signals in blood. Science 359, 866–867 (2018).10.1126/science.aas9102 ↗
5. Sengupta, S. & Sasisekharan, R. Exploiting nanotechnology to target cancer. Br. J. Cancer 96, 1315–1319 (2007).10.1038/sj.bjc.6603707 ↗
6. Madamsetty, V. S., Paul, M. K., Mukherjee, A. & Mukherjee, S. Functionalization of nanomaterials and their application in melanoma cancer theranostics. ACS Biomater. Sci. Eng. 61, 167–181 (2020).10.1021/acsbiomaterials.9b01426 ↗
7. Song, W., Anselmo, A. C. & Huang, L. Nanotechnology intervention of the microbiome for cancer therapy. Nat. Nanotechnol. 14, 1093–1103 (2019).10.1038/s41565-019-0589-5 ↗
8. Chen, J. et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials 237, 119827 (2020).10.1016/j.biomaterials.2020.119827 ↗
9. Pasinszki, T., Krebsz, M., Tung, T. T. & Losic, D. Carbon nanomaterial based biosensors for non-invasive detection of cancer and disease biomarkers for clinical diagnosis. Sensors 17, 1919 (2017).10.3390/s17081919 ↗
10. Yu, X. et al. Graphene-based smart materials. Nat. Rev. Mater. 2, 17046 (2017).10.1038/natrevmats.2017.46 ↗
11. Liu, Y., Dong, X. & Chen, P. Biological and chemical sensors based on graphene materials. Chem. Soc. Rev. 41, 2283–2307 (2012).10.1039/C1CS15270J ↗
12. Kostarelos, K. & Novoselov, K. S. Graphene devices for life. Nat. Nanotechnol. 9, 744–745 (2014).10.1038/nnano.2014.224 ↗
13. Yang, Y., Asiri, A. M., Tang, Z., Du, D. & Lin, Y. Graphene based materials for biomedical applications. Mater. Today 16, 365–373 (2013).10.1016/j.mattod.2013.09.004 ↗
14. Keefe, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537–550 (2010).10.1038/nrd3141 ↗
15. Hermann, T. & Patel, D. J. Adaptive recognition by nucleic acid aptamers. Science 287, 820–825 (2000).10.1126/science.287.5454.820 ↗
16. Farokhzad, O. C. et al. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 64, 7668–7672 (2004).10.1158/0008-5472.CAN-04-2550 ↗
17. Cheng, C., Li, S., Thomas, A., Kotov, N. A. & Haag, R. Functional graphene nanomaterials based architectures: biointeractions, fabrications, and emerging biological applications. Chem. Rev. 117, 1826–1914 (2017).10.1021/acs.chemrev.6b00520 ↗
18. Urmann, K., Modrejewski, J., Scheper, T. & Walter, J.-G. Aptamer-modified nanomaterials: principles and applications. Bionanomaterials 18, 20160012 (2017).
19. Liu, Q. et al. Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy. NPG Asia Mater. 6, e95 (2014).10.1038/am.2014.12 ↗
20. Bock, L. C., Griffin, L. C., Latham, J. A., Vermass, E. H. & Toole, J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564–566 (1992).10.1038/355564a0 ↗
21. Sekhon, S. S. et al. Defining the copper binding aptamotif and aptamer integrated recovery platform (AIRP). Nanoscale 9, 2883–2894 (2017).10.1039/C6NR09408B ↗
22. Dunn, M. R., Jimenez, R. M. & Chaput, J. C. Analysis of aptamer discovery and technology. Nat. Rev. Chem. 1, 0076 (2017).10.1038/s41570-017-0076 ↗
23. Sekhon, S. S. et al. Aptabody–aptatope interactions in aptablotting assays. Nanoscale 9, 7464–7475 (2017).10.1039/C7NR01827D ↗
24. Sun, H. & Zu, Y. Aptamers and their applications in nanomedicine. Small 11, 2352–2364 (2015).10.1002/smll.201403073 ↗
25. Porciani, D. et al. Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines. Nat. Commun. 9, 2283 (2018).10.1038/s41467-018-04691-x ↗
26. Ho, L. C. et al. Aptamer-conjugated polymeric nanoparticles for the detection of cancer cells through “turn-on” retro-self-quenched fluorescence. Anal. Chem. 87, 4925–4932 (2015).10.1021/acs.analchem.5b00569 ↗
27. Meng, H. M., Fu, T., Zhang, X. B. & Tan, W. Cell-SELEX-based aptamer-conjugated nanomaterials for cancer diagnosis and therapy. Natl Sci. Rev. 2, 71–84 (2015).10.1093/nsr/nwv001 ↗
28. Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818–822 (1990).10.1038/346818a0 ↗
29. Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990).10.1126/science.2200121 ↗
30. Darmostuk, M., Rimpelova, S., Gbelcova, H. & Ruml, T. Current approaches in SELEX: an update to aptamer selection technology. Biotechnol. Adv. 33, 1141–1161 (2015).10.1016/j.biotechadv.2015.02.008 ↗
31. Blind, M. & Blank, M. Aptamer selection technology and recent advances. Mol. Ther. Nucleic Acids 4, e223 (2015).10.1038/mtna.2014.74 ↗
32. Mi, J. et al. In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol. 6, 22–24 (2010).10.1038/nchembio.277 ↗
33. Keefe, A. D. & Cload, S. T. SELEX with modified nucleotides. Curr. Opin. Chem. Biol. 12, 448–456 (2008).10.1016/j.cbpa.2008.06.028 ↗
34. Lee, J. F., Stovall, G. M. & Ellington, A. D. Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Curr. Opin. Chem. Biol. 10, 282–289 (2006).10.1016/j.cbpa.2006.03.015 ↗
35. Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M. & Gold, L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl Acad. Sci. USA 100, 15416–15421 (2003).10.1073/pnas.2136683100 ↗
36. Sefah, K., Shangguan, D., Xiong, X., O’donoghue, M. B. & Tan, W. Development of DNA aptamers using Cell-SELEX. Nat. Protoc. 5, 1169–1185 (2010).10.1038/nprot.2010.66 ↗
37. Mayer, G. et al. Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat. Protoc. 5, 1993–2004 (2010).10.1038/nprot.2010.163 ↗
38. Geim, A. K. & Novoselov, K. S. The rise of graphene. Nat. Mater. 6, 183–191 (2007).10.1038/nmat1849 ↗
39. Barkan, T. Graphene: the hype versus commercial reality. Nat. Nanotechnol. 14, 904–910 (2019).10.1038/s41565-019-0556-1 ↗
40. Kaur, P. et al. Non-covalent functionalization of graphene with poly (diallyl dimethylammonium) chloride: effect of a non-ionic surfactant. Int. J. Hydrog. Energy 40, 1541–1547 (2015).10.1016/j.ijhydene.2014.11.068 ↗
41. Dreyer, D. R., Park, S., Bielawski, C. W. & Ruoff, R. S. The chemistry of graphene oxide. Chem. Soc. Rev. 39, 228–240 (2010).10.1039/B917103G ↗
42. Deng, N. et al. Aptamer-conjugated gold functionalized graphene oxide nanocomposites for human α-thrombin specific recognition. J. Chromatogr. A 1427, 16–21 (2016).10.1016/j.chroma.2015.12.018 ↗
43. Cruz, S., Girão, A., Gonçalves, G. & Marques, P. Graphene: the missing piece for cancer diagnosis? Sensors 16, 137 (2016).10.3390/s16010137 ↗
44. Jacoby, M. 2-D materials go beyond graphene. Chem. Eng. News 95, 36–40 (2017).
45. Bolotsky, A. et al. Two dimensional materials in biosensing and healthcare: from in vitro diagnostics to optogenetics and beyond. ACS Nano 13, 9781–9810 (2019).10.1021/acsnano.9b03632 ↗
46. Fusco, L. et al. Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics. Theranostics 10, 5435–5488 (2020).10.7150/thno.40068 ↗
47. Novoselov, K. S. et al. Electric field effect in atomically thin carbon films. Science 306, 666–669 (2004).10.1126/science.1102896 ↗
48. Hernandez, Y. et al. High-yield production of graphene by liquid-phase exfoliation of graphite. Nat. Nanotechnol. 3, 563–568 (2008).10.1038/nnano.2008.215 ↗
49. Liu, B. et al. From Graphite to graphene oxide and graphene oxide quantum dots. Small 13, 1601001 (2017).10.1002/smll.201601001 ↗
50. Pumera, M., Ambrosi, A., Bonanni, A., Chng, E. L. K. & Poh, H. L. Graphene for electrochemical sensing and biosensing. Trends Anal. Chem. 29, 954–965 (2010).10.1016/j.trac.2010.05.011 ↗
51. Biju, V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem. Soc. Rev. 43, 744–764 (2014).10.1039/C3CS60273G ↗
52. Sutter, P. W., Flege, J. I. & Sutter, E. A. Epitaxial graphene on ruthenium. Nat. Mater. 7, 406–411 (2008).10.1038/nmat2166 ↗
53. Du, Y., Guo, S., Qin, H., Dong, S. & Wang, E. Target-induced conjunction of split aptamer as new chiral selector for oligopeptide on graphene–mesoporous silica–gold nanoparticle hybrids modified sensing platform. ChemComm 48, 799–801 (2012).
54. Sun, Y., Yang, S., Zhao, G., Wang, Q. & Wang, X. Adsorption of polycyclic aromatic hydrocarbons on graphene oxides and reduced graphene oxides. Chem. Asian J. 8, 2755–2761 (2013).10.1002/asia.201300496 ↗
55. Liu, Z., Robinson, J. T., Sun, X. & Dai, H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876–10877 (2008).10.1021/ja803688x ↗
56. Nellore, B. P. V. et al. Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells. Bioconjugate Chem. 26, 235–242 (2015).10.1021/bc500503e ↗
57. Chang, Y., Wang, M., Wang, L. & Xia, N. Recent progress in electrochemical biosensors for detection of prostate-specific antigen. Int. J. Electrochem. Sci. 13, 4071–4084 (2018).10.20964/2018.05.24 ↗
58. Mayer, G. The chemical biology of aptamers. Angew. Chem. Int. Ed. 48, 2672–2689 (2009).10.1002/anie.200804643 ↗
59. Lupold, S. E., Hicke, B. J., Lin, Y. & Coffey, D. S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62, 4029–4033 (2002).
60. Svobodova, M., Bunka, D. H., Nadal, P., Stockley, P. G. & O’Sullivan, C. K. Selection of 2′ F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications. Anal. Bioanal. Chem. 405, 9149–9157 (2013).10.1007/s00216-013-7350-y ↗
61. Heydari-Bafrooei, E. & Shamszadeh, N. S. Electrochemical bioassay development for ultrasensitive aptasensing of prostate specific antigen. Biosens. Bioelectron. 91, 284–292 (2017).10.1016/j.bios.2016.12.048 ↗
62. Ueno, Y. et al. On-chip graphene oxide aptasensor for multiple protein detection. Anal. Chim. Acta 866, 1–9 (2015).10.1016/j.aca.2014.10.047 ↗
63. Pan, L. H. et al. An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide/ssDNA/PLLA nanoparticles. Biosens. Bioelectron. 89, 598–605 (2017).10.1016/j.bios.2016.01.077 ↗
64. Fang, B. Y., Wang, C. Y., Li, C., Wang, H. B. & Zhao, Y. D. Amplified using DNase I and aptamer/graphene oxide for sensing prostate specific antigen in human serum. Sens. Actuators B 244, 928–933 (2017).10.1016/j.snb.2017.01.045 ↗
65. Jolly, P. et al. Aptamer–MIP hybrid receptor for highly sensitive electrochemical detection of prostate specific antigen. Biosens. Bioelectron. 75, 188–195 (2016).10.1016/j.bios.2015.08.043 ↗
66. Jo, H. & Ban, C. Aptamer–nanoparticle complexes as powerful diagnostic and therapeutic tools. Exp. Mol. Med. 48, e230 (2016).10.1038/emm.2016.44 ↗
67. Boyacioglu, O., Stuart, C. H., Kulik, G. & Gmeiner, W. H. Dimeric DNA aptamer complexes for high-capacity–targeted drug delivery using pH-sensitive covalent linkages. Mol. Ther. Nucleic Acids 2, e107 (2013).10.1038/mtna.2013.37 ↗
68. Tan, J. et al. A graphene oxide-based fluorescent aptasensor for the turn-on detection of CCRF-CEM. Nanoscale Res. Lett. 13, 66 (2018).10.1186/s11671-017-2403-3 ↗
69. Lou, B., Zhou, Z., Gu, W. & Dong, S. Microelectrodes integrated into a microfluidic chip for the detection of CCRF-CEM cells based on the electrochemical oxidation of hydrazine. ChemElectroChem 3, 2008–2011 (2016).10.1002/celc.201600151 ↗
70. Lai, Z. et al. An ‘activatable’aptamer-based fluorescence probe for the detection of HepG2 cells. Oncol. Rep. 37, 2688–2694 (2017).10.3892/or.2017.5527 ↗
71. Xiao, K., Liu, J., Chen, H., Zhang, S. & Kong, J. A label-free and high-efficient GO-based aptasensor for cancer cells based on cyclic enzymatic signal amplification. Biosens. Bioelectron. 91, 76–81 (2017).10.1016/j.bios.2016.11.057 ↗
72. Cao, L. et al. Visual and high-throughput detection of cancer cells using a graphene oxide-based FRET aptasensing microfluidic chip. Lab Chip 12, 4864–4869 (2012).10.1039/c2lc40564d ↗
73. Tabrizi, M. A., Shamsipur, M., Saber, R. & Sarkar, S. Flow injection amperometric sandwich-type aptasensor for the determination of human leukemic lymphoblast cancer cells using mwcnts-pdnano/ptca/aptamer as labeled aptamer for the signal amplification. Anal. Chim. Acta 985, 61–68 (2017).10.1016/j.aca.2017.07.054 ↗
74. Yan, L. A. et al. A versatile activatable fluorescence probing platform for cancer cells in vitro and in vivo based on self-assembled aptamer/carbon nanotube ensembles. Anal. Chem. 86, 9271–9277 (2014).10.1021/ac5024149 ↗
75. Ciui, B., Tertis, M., Peia, D., Cristea, C. & Sandulescu, R. Graphene oxide modified aptasensor for the MUCIN 1 detection. Farmacia 64, 43–47 (2016).
76. Mohammadpour, Z. & Majidzadeh-A, K. Applications of two-dimensional nanomaterials in breast cancer theranostics. ACS Biomater. Sci. Eng. 6, 1852–1873 (2020).10.1021/acsbiomaterials.9b01894 ↗
77. Li, Q. et al. Graphene-nanoparticle-based self-healing hydrogel in preventing postoperative recurrence of breast cancer. ACS Biomater. Sci. Eng. 5, 768–779 (2019).10.1021/acsbiomaterials.8b01475 ↗
78. Li, J. & Pu, K. Semiconducting polymer nanomaterials as near-infrared photoactivatable protherapeutics for cancer. Acc. Chem. Res. 53, 752–762 (2020).10.1021/acs.accounts.9b00569 ↗
79. Wei, W., Li, D. F., Pan, X. H. & Liu, S. Q. Electrochemiluminescent detection of Mucin 1 protein and MCF-7 cancer cells based on the resonance energy transfer. Analyst 137, 2101–2106 (2012).10.1039/c2an35059a ↗
80. Cheng, A. K., Su, H., Wang, Y. A. & Yu, H. Z. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout. Anal. Chem. 81, 6130–6139 (2009).10.1021/ac901223q ↗
81. He, Y., Lin, Y., Tang, H. & Pang, D. A graphene oxide-based fluorescent aptasensor for the turn-on detection of epithelial tumor marker mucin 1. Nanoscale 4, 2054–2059 (2012).10.1039/c2nr12061e ↗
82. Yang, L. et al. Photothermal therapeutic response of cancer cells to aptamer–gold nanoparticle-hybridized graphene oxide under NIR illumination. ACS Appl. Mater. Interfaces 7, 5097–5106 (2015).10.1021/am508117e ↗
83. Bahreyni, A. et al. Identification and imaging of leukemia cells using dual-aptamer-functionalized graphene oxide complex. J. Biomater. Appl. 32, 74–81 (2017).10.1177/0885328217712111 ↗
84. Ding, Y. et al. Fluorescent detection of Mucin 1 protein based on aptamer functionalized biocompatible carbon dots and graphene oxide. Anal. Methods 7, 7792–7798 (2015).10.1039/C5AY01680K ↗
85. Wang, X. et al. Aptamer–conjugated graphene oxide–gold nanocomposites for targeted chemo-photothermal therapy of cancer cells. J. Mater. Chem. B 3, 4036–4042 (2015).10.1039/C5TB00134J ↗
86. Huang, R. C., Chiu, W. J., Lai, I. P. & Huang, C. C. Multivalent aptamer/gold nanoparticle–modified graphene oxide for mass spectrometry–based tumor tissue imaging. Sci. Rep. 5, 10292 (2015).10.1038/srep10292 ↗
87. Shen, Z., Wu, A. & Chen, X. Current detection technologies for circulating tumor cells. Chem. Soc. Rev. 46, 2038–2056 (2017).10.1039/C6CS00803H ↗
88. Ming, Y. et al. Circulating tumor cells: from theory to nanotechnology-based detection. Front. Pharmacol. 8, 35 (2017).10.3389/fphar.2017.00035 ↗
89. Zheng, F. et al. Aptamer-functionalized barcode particles for the capture and detection of multiple types of circulating tumor cells. Adv. Mater. 26, 7331–7338 (2014).10.1002/adma.201403530 ↗
90. Nellore, B. P. V. et al. Aptamer-conjugated theranostic hybrid graphene oxide with highly selective biosensing and combined therapy capability. Faraday Discuss. 175, 257–271 (2015).10.1039/C4FD00074A ↗
91. Bahreyni, A. et al. A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells. Int. J. Pharm. 526, 391–399 (2017).10.1016/j.ijpharm.2017.05.014 ↗
92. Li, J., Hu, X., Shi, S., Zhang, Y. & Yao, T. Three label-free thrombin aptasensors based on aptamers and [Ru (bpy) 2 (o-mopip)] 2. J. Mater. Chem. B 4, 1361–1367 (2016).10.1039/C5TB02032H ↗
93. Wang, C. F., Wang, Z. G., Sun, X. Y., Chen, M. J. & Lv, Y. K. An ultrasensitive fluorescent aptasensor for detection of cancer marker proteins based graphene oxide–ssDNA. RSC Adv. 8, 41143–41149 (2018).10.1039/C8RA08078J ↗
94. Tabasi, A., Noorbakhsh, A. & Sharifi, E. Reduced graphene oxide-chitosan-aptamer interface as new platform for ultrasensitive detection of human epidermal growth factor receptor 2. Biosens. Bioelectron. 95, 117–123 (2017).10.1016/j.bios.2017.04.020 ↗
95. Song, E. A graphene oxide-based FRET sensor for rapid and sensitive detection of matrix metalloproteinase 2 in human serum sample. Biosens. Bioelectron. 47, 445–450 (2013).10.1016/j.bios.2013.03.030 ↗
96. Al-Ogaidi, I. et al. Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots. ChemComm 50, 1344–1346 (2014).
97. Suvarnaphaet, P. & Pechprasarn, S. Graphene-based materials for biosensors: a review. Sensors 17, 2161 (2017).10.3390/s17102161 ↗
98. Wang, Y. et al. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. J. Am. Chem. Soc. 132, 9274–9276 (2010).10.1021/ja103169v ↗
99. Feng, L., Chen, Y., Ren, J. & Qu, X. A graphene functionalized electrochemical aptasensor for selective label-free detection of cancer cells. Biomaterials 32, 2930–2937 (2011).10.1016/j.biomaterials.2011.01.002 ↗
100. Huang, X. et al. Graphene-based materials: synthesis, characterization, properties, and applications. Small 7, 1876–1902 (2011).10.1002/smll.201002009 ↗